SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 149 filers reported holding SERES THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $791 | -47.5% | 331,861 | +5.5% | 0.00% | – |
| Q2 2023 | $1,507 | -54.5% | 314,427 | -46.2% | 0.00% | – |
| Q1 2023 | $3,313 | +1.5% | 584,072 | +0.3% | 0.00% | -100.0% |
| Q4 2022 | $3,263 | -99.9% | 582,544 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $3,680,000 | +88.6% | 572,991 | +0.8% | 0.00% | – |
| Q2 2022 | $1,951,000 | -51.8% | 568,709 | +0.1% | 0.00% | – |
| Q1 2022 | $4,046,000 | -13.3% | 568,209 | +1.4% | 0.00% | – |
| Q4 2021 | $4,669,000 | -50.7% | 560,564 | -58.8% | 0.00% | -100.0% |
| Q3 2021 | $9,469,000 | -71.4% | 1,360,523 | -2.0% | 0.00% | -66.7% |
| Q2 2021 | $33,100,000 | +13.4% | 1,387,839 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $29,183,000 | -36.8% | 1,417,342 | -24.7% | 0.00% | -40.0% |
| Q4 2020 | $46,140,000 | +180.0% | 1,883,260 | +223.5% | 0.01% | +150.0% |
| Q3 2020 | $16,481,000 | +13084.8% | 582,151 | +2123.6% | 0.00% | – |
| Q2 2020 | $125,000 | -35.6% | 26,180 | -51.7% | 0.00% | – |
| Q1 2020 | $194,000 | +4.3% | 54,234 | +0.6% | 0.00% | – |
| Q4 2019 | $186,000 | -11.4% | 53,934 | +2.9% | 0.00% | – |
| Q3 2019 | $210,000 | +25.7% | 52,433 | +0.8% | 0.00% | – |
| Q2 2019 | $167,000 | -73.1% | 52,008 | -42.5% | 0.00% | – |
| Q1 2019 | $621,000 | +33.0% | 90,377 | -12.5% | 0.00% | – |
| Q4 2018 | $467,000 | -40.4% | 103,287 | +0.0% | 0.00% | – |
| Q3 2018 | $784,000 | -11.6% | 103,247 | +0.1% | 0.00% | – |
| Q2 2018 | $887,000 | +17.2% | 103,101 | 0.0% | 0.00% | – |
| Q1 2018 | $757,000 | -27.6% | 103,101 | +0.0% | 0.00% | – |
| Q4 2017 | $1,045,000 | -84.8% | 103,061 | -75.9% | 0.00% | -100.0% |
| Q3 2017 | $6,861,000 | +30.7% | 427,723 | -7.9% | 0.00% | 0.0% |
| Q2 2017 | $5,248,000 | -35.0% | 464,423 | -35.2% | 0.00% | -50.0% |
| Q1 2017 | $8,078,000 | +8.5% | 716,795 | -4.6% | 0.00% | +100.0% |
| Q4 2016 | $7,442,000 | -19.6% | 751,680 | -0.2% | 0.00% | -50.0% |
| Q3 2016 | $9,260,000 | -72.2% | 753,480 | -34.3% | 0.00% | -71.4% |
| Q2 2016 | $33,337,000 | +32.0% | 1,147,577 | +20.7% | 0.01% | +40.0% |
| Q1 2016 | $25,254,000 | -25.2% | 950,830 | -1.1% | 0.01% | -28.6% |
| Q4 2015 | $33,744,000 | +21.3% | 961,650 | +0.3% | 0.01% | +16.7% |
| Q3 2015 | $27,816,000 | -28.7% | 959,010 | -0.2% | 0.01% | -25.0% |
| Q2 2015 | $39,032,000 | – | 961,076 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |